CENDAKIMAB
UNII O8R9U9ZUVN

Substance Identification & Data

This profile provides standardized clinical and technical data for Cendakimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O8R9U9ZUVN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2151032-62-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O8R9U9ZUVN

CAS Registry Number

2151032-62-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CENDAKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174792

National Cancer Institute reference terminology for clinical and research data.

INN ID

10990

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-139

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cendakimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CENDAKIMAB

Common Names & Synonyms

CENDAKIMAB [INN]

CENDAKIMAB [USAN]

CENDAKIMAB [WHO-DD]

HUMANIZED ANTI-HUMAN IL-13 MONOCLONAL ANTIBODY

Systematic Nomenclature

IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER

SYS

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL-13 (INTERLEUKIN 13, IL-13)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV2-5*08 (80.6%) -(IGHD) -IGHJ4*01 (100%)) (10.7.15) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (220) (124-221), HINGE (222-236), CH2 L1.3>A (240), L1.2>A (241) (237-346), CH3 E12 (362), M14 (364) (347-451), CHS (452-453)) (124-453)), (226-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (85.3%) - IGKJ4*01 (100%)) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (100%) A45.1 (153), V101 (191) (108'-214'))DIMER (232-232'':235-235'')- BISDISULFIDE

SYS